Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor embolization is a minimally invasive interventional radiology procedure in which the arterial blood supply to a tumor is deliberately blocked using embolic materials such as particles, microspheres, coils, or chemical agents. The goal is to induce tumor ischemia and necrosis, often as a palliative measure or to reduce surgical blood loss. Embolization can be combined with localized chemotherapy (transarterial chemoembolization, TACE) or radiotherapy (radioembolization), allowing high local drug concentrations while minimizing systemic exposure. Tumor embolization is used in the management of various malignant and some benign solid tumors, particularly when surgical resection is not feasible or as a bridge to surgery or transplantation. This technique is not a molecular target, receptor, enzyme, or transporter, but a therapeutic process[1][2][3][4][5][6][7][8].
Physical/chemical blockade of arterial blood flow to tumor tissue, causing ischemia and necrosis[1][2][4][5][6][7]. Local delivery of chemotherapeutics (in TACE) or radiotherapeutics (in radioembolization) directly to the tumor via its arterial supply[3][5][6].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor embolization (arterial supply).